PubRank

Michelle S Hirsch

Author PubWeight™ 64.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 2007 5.68
2 Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 2011 4.46
3 Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 2008 2.50
4 Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study. Lancet Oncol 2012 2.44
5 Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s). Urology 2010 2.31
6 Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Gynecol Oncol 2011 1.87
7 Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol 2012 1.86
8 High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod Pathol 2010 1.80
9 A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol 2011 1.64
10 Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol 2009 1.62
11 PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol 2010 1.57
12 PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors. Am J Surg Pathol 2010 1.54
13 Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix. Cancer 2013 1.52
14 Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med 2012 1.42
15 Evidence supporting the existence of benign teratomas of the postpubertal testis: a clinical, histopathologic, and molecular genetic analysis of 25 cases. Am J Surg Pathol 2013 1.42
16 Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival. Neoplasia 2010 1.36
17 Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer. PLoS One 2012 1.31
18 Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol 2014 1.30
19 Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol 2010 1.26
20 Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clin Cancer Res 2008 1.23
21 Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma. Cancer 2010 1.19
22 Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers. Cancer Res 2013 1.09
23 Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. Am J Surg Pathol 2014 1.08
24 Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. Hum Pathol 2004 1.07
25 Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma. Gynecol Oncol 2009 1.03
26 BRAF mutations in metanephric adenoma of the kidney. Eur Urol 2012 1.02
27 Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas. Diagn Mol Pathol 2011 1.01
28 Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria. Mod Pathol 2009 1.00
29 Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. Int J Cancer 2008 0.99
30 Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor. Am J Surg Pathol 2015 0.97
31 Models of care and NCCN guideline adherence in very-low-risk prostate cancer. J Natl Compr Canc Netw 2013 0.95
32 FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Med 2014 0.95
33 A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib. Clin Genitourin Cancer 2009 0.94
34 Histological 'progression' from low (LSIL) to high (HSIL) squamous intraepithelial lesion is an uncommon event and an indication for quality assurance review. Mod Pathol 2010 0.93
35 Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol 2008 0.85
36 Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity. Am J Surg Pathol 2013 0.85
37 Histologic and immunohistochemical decision-making in endometrial adenocarcinoma. Mod Pathol 2008 0.84
38 PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas. Histopathology 2012 0.84
39 MOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA. Diagn Histopathol (Oxf) 2010 0.83
40 Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomies. Mod Pathol 2010 0.82
41 Pagetoid lesions of the vulva: a collision between malignant melanoma and extramammary Paget disease. Int J Gynecol Pathol 2008 0.81
42 Differential expression of p-ERM, a marker of cell polarity, in benign and neoplastic oviductal epithelium. Int J Gynecol Pathol 2013 0.80
43 A weakly positive human papillomavirus Hybrid Capture II result correlates with a significantly lower risk of cervical intraepithelial neoplasia 2,3 after atypical squamous cells of undetermined significance cytology. J Low Genit Tract Dis 2010 0.79
44 Mucinous tubular and spindle cell carcinoma of the kidney: imaging features. Cancer Imaging 2012 0.77
45 Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma. Histopathology 2015 0.77
46 Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors. Int J Gynecol Pathol 2009 0.77
47 Renal angiomyoadenomatous tumour: Imaging features. Can Urol Assoc J 2012 0.76
48 Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer. Int J Clin Oncol 2010 0.76
49 GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract. Am J Surg Pathol 2015 0.76
50 Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract. Am J Surg Pathol 2009 0.75
51 The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod Pathol 2003 0.75
52 Identical karyotypes in synchronous bilateral clear cell renal cell carcinomas. Cancer Genet Cytogenet 2002 0.75
53 A 57-year-old man with abdominal ascites and ventral hernia. Urology 2010 0.75
54 Unresorbed corpora albicantia mimicking a sonographically solid ovarian mass in a postmenopausal woman. J Ultrasound Med 2004 0.75
55 Neuroepithelial tumor arising in a testicular teratoma with retroperitoneal metastasis. J Clin Oncol 2012 0.75